smartbax GmbH
PrivateLast Round
Early Funding
Jun 30, 2026
Total Funding Raised
$16.51M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
smartbax GmbH is a biotechnology company that develops a new generation of antibiotics to address the increasing spread of multidrug-resistant bacteria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
smartbax GmbH Comparables
Compare smartbax GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MyxoBiomedical | 87% | |
| Arivin Therapeutics | 83% | |
| Santero Therapeutics | 83% |
smartbax GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 30, 2026 | ||||
| Series A | Oct 22, 2025 | ||||
| Seed | May 23, 2023 | ||||
| Pre Seed | Apr 1, 2021 |
smartbax GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Seed |
| Boehringer Ingelheim Venture Fund | Early Funding, Series A, Seed, Pre Seed |
| Bayern Kapital | Early Funding, Series A |
| Unternehmertum | Series A |
| High-Tech Gründerfonds | Early Funding, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
$7M raised with Bayern Kapital leading.
- Jun 18, 2026
Monthly visitors grew 3074% MoM, from 23 to 730.
Recent news
Latest coverage and updates
- receives_financingJun 30, 2026
smartbax GmbH received financing of $7.2M in Pre Series A on Jun 30th '26.
smartbax GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about smartbax GmbH's valuation, stock price, and market status.
Is smartbax GmbH a public or private company?
smartbax GmbH is a private company.
What is the current stock price of smartbax GmbH?
smartbax GmbH is a private company with no public stock price. No recent secondary market data is available.
How much is smartbax GmbH worth (valuation)?
Valuation information for smartbax GmbH is not publicly available.
Can I buy smartbax GmbH stock?
smartbax GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was smartbax GmbH's last funding round?
smartbax GmbH's most recent funding round was Early Funding on June 30, 2026.
Who are the main investors in smartbax GmbH?
Key investors in smartbax GmbH include Boehringer Ingelheim, Boehringer Ingelheim Venture Fund, Bayern Kapital, High-Tech Gründerfonds.
Will smartbax GmbH IPO soon?
No public IPO plans have been announced for smartbax GmbH.
How can I track smartbax GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor smartbax GmbH's secondary market activity and sign up for updates.